No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement
Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D
, Chataway, J and Schmierer, K
(2015).
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement.
[Dataset].
Neurology: Neuroimmunology & Neuroinflammation.
https://doi.org/10.1212/NXI.0000000000000158
, Chataway, J and Schmierer, K
(2015).
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine: Data supplement.
[Dataset].
Neurology: Neuroimmunology & Neuroinflammation.
https://doi.org/10.1212/NXI.0000000000000158
Supplementary data published as part of a comparison of the cancer risk of cladribine and other disease-modifying drugs (DMDs) in trials containing people with relapsing multiple sclerosis (pwRMS).
Keywords
Multiple sclerosis; Cancer; Cladribine| Item Type | Dataset |
|---|---|
| Resource Type |
Resource Type Resource Description Dataset Quantitative |
| Capture method | Experiment |
| Date | 1 October 2015 |
| Language(s) of written materials | English |
| Creator(s) |
Pakpoor, J, Disanto, G, Altmann, D, Pavitt, S, Turner, BP, Marta, M, Juliusson, G, Baker, D, Chataway, J and Schmierer, K
|
| LSHTM Faculty/Department |
Faculty of Epidemiology and Population Health > Dept of Medical Statistics Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology (-2019) |
| Participating Institutions | London School of Hygiene & Tropical Medicine |
| Funders |
Project Funder Grant Number Funder URI |
| Date Deposited | 20 Oct 2015 10:46 |
| Last Modified | 08 Jul 2021 12:51 |
| Publisher | Neurology: Neuroimmunology & Neuroinflammation |
No files available. Please consult associated links.
